drugset / Trial / NCT00324298

Bleomycin, Etoposide, and Cisplatin in Treating Patients With Metastatic Germ Cell Cancer of the Testicles

NCT00324298

Phase 3 Completed 210 enrolled Queen Mary University of London
RandomizedTreatment

Summary

RATIONALE: Drugs used in chemotherapy, such as bleomycin, etoposide, and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) may kill more tumor cells. It is not yet known which schedule of bleomycin is more effective when given together with etoposide and cisplatin in treating metastatic germ cell cancer of the testicles. PURPOSE: This randomized phase III trial is studying two different schedules of bleomycin to compare how well they work when given together with etoposide and cisplatin in treating patients with metastatic germ cell cancer of the testicles.

Timeline

Start
2003-07
Primary completion
Completion
2011-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Bleomycin Unknown Intravenous
Background Cisplatin Other / unclassified Intravenous
Background Etoposide Small molecule Intravenous